Navigation Links
Benicar HCT Reductions in Seated Systolic Blood Pressure for Stage,2 Patients Compared With Amlodipine + Benazepril

d commercialization of innovative medicines that improve the lives of patients throughout the world.

The primary focus of Daiichi Sankyo's research and development is cardiovascular disease, including therapies for dyslipidemia, hypertension, diabetes, and acute coronary syndrome. The company is also pursuing the discovery of new medicines in the areas of glucose metabolic disorders, infectious diseases, cancer, bone and joint diseases, and immune disorders.

For more information, please visit www.dsus.com.

About Forest Laboratories and Its Products

Forest Laboratories' growing line of products includes: Lexapro(R) (escitalopram oxalate), an SSRI antidepressant indicated for the initial and maintenance treatment of major depressive disorder and for generalized anxiety disorder in adults; Namenda(R) (memantine HCI), an N-methyl-D-aspartate (NMDA)-receptor antagonist indicated for the treatment of moderate to severe Alzheimer's disease; Benicar(R)** (olmesartan medoxomil), an angiotensin receptor blocker indicated for the treatment of hypertension; Benicar* HCT(R) (olmesartan medoxomil hydrochlorothiazide), an angiotensin receptor blocker and diuretic combination product is not indicated for initial therapy; Campral(R)** (acamprosate calcium), a glutamate receptor modulator, indicated for the maintenance of abstinence from alcohol in patients with alcohol dependence who are abstinent at treatment initiation in combination with psychosocial support; and Combunox(TM) (Oxycodone HCI and Ibuprofen), an opioid and NSAID combination indicated for the short-term management of acute, moderate to severe pain.

Except for historical information contained herein, this release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These statements are subject to risks and uncertainties that affect our business, including risk factors list
'"/>




Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Anesiva Announces Phase 2 Data Showing Substantial, Long-Term Pain Reductions with Adlea(TM) (formerly 4975) in Osteoarthritis of the Knee
2. A 4-Week Therapy with Transition Therapeutics E1-I.N.T. Leads to Sustained Reductions in Blood Glucose Levels for 6 Months Post-treatment in Type 2 Diabetes Patients
3. Byetta Treatment for Three and a Half Years Associated with Reductions in Cardiovascular Risk Factors in People with Type 2 Diabetes
4. DiObex Presents Phase 2a Data of DIO-902 Demonstrating Trends of Improved Glycemic Control and Significant Reductions of LDL-Cholesterol and C-Reactive Protein
5. Human Genome Sciences Reports That a Phase 2 Study of LymphoStat-B Showed Significant Reductions in Disease Activity in Patients with Active Systemic Lupus Erythematosus
6. Medtronic Updates Long-Term ENDEAVOR I-II Clinical Data Showing Sustained Safety and Significant Reductions in Repeat Procedures
7. Lipitor Provides Unprecedented Cardiovascular Risk Reductions in Diabetes Patients with Metabolic Syndrome and in Stroke Patients
8. Rapid Whole Blood Testing for Infectious Mononucleosis Antibodies
9. Blood Gas Analysis: The Pros and Cons of Point-Of-Care Testing
10. Bio-Matrix Scientifics Dr. ONeill Sees University of Pittsburghs Published Study on Culture Blood-Forming Stem Cells from Human Fat Tissue as Supporting Near Term Benefits of Banking Adipose (Fat) Derived Stem Cells
11. New Data from Multiple Studies Show Galvus Delivers Consistent and Robust Blood Sugar Control in Patients with Type 2 Diabetes

Post Your Comments:
(Date:12/1/2009).... 1 Former New Jersey As...ed when his radiotherapy treatment sessions for pr...to less than five. Midway through his course of t...Cancer Center acquired the region,s first Rapid...ical Systems (NYSE: VAR ), making it possible fo...
(Date:12/1/2009)...Newswire/ -- The new position of Executive Vice Pr...logies, Inc. has been taken up by Howard Goldstein...0 years of experience creating and managing life s...irect Microchip Biotechnologies, marketing, busine...ons as the company makes the transition from produ...
(Date:12/1/2009)... Galenea Corp. and Otsuka Pharmaceu...ion of their research and development collaboratio...he collaboration term to seven years and brings th...lion. The companies have been working together si...developing first-in-class therapies for schizophre...
Breaking Medicine Technology:Fighting Prostate Cancer With Speed and Accuracy: RapidArc(R) Radiotherapy Available at the Delaware Valley Urology Cancer Treatment Center 2Fighting Prostate Cancer With Speed and Accuracy: RapidArc(R) Radiotherapy Available at the Delaware Valley Urology Cancer Treatment Center 3Fighting Prostate Cancer With Speed and Accuracy: RapidArc(R) Radiotherapy Available at the Delaware Valley Urology Cancer Treatment Center 4Fighting Prostate Cancer With Speed and Accuracy: RapidArc(R) Radiotherapy Available at the Delaware Valley Urology Cancer Treatment Center 5Howard Goldstein Joins Microchip Biotechnologies, Inc. as Executive Vice President 2Galenea and Otsuka Announce Second Extension to Schizophrenia Research Collaboration 2Galenea and Otsuka Announce Second Extension to Schizophrenia Research Collaboration 3UT School of Public Health researchers develop game for HIV+ youth 49792 1UT School of Public Health researchers develop game for HIV+ youth 49792 2Bycatch whaling a growing threat to coastal whales 8973 1Bycatch whaling a growing threat to coastal whales 8973 2Experimental Urine Test Spots Appendicitis 49786 1Experimental Urine Test Spots Appendicitis 49786 2
...ncer diagnosis , , TAMPA, Fla., May 14 Moffitt...ve signed a license agreement on phospholipid biom...h has been granted exclusive worldwide rights to M...tiation, developmental milestone and license maint...rantz BioMarkers will collaborate on ovarian cance...
...poration (NYSE: BSX ) today announced data from ...al-word survival rates for implantable cardiac dev... ALTITUDE analyzes outcomes data from patients mo...em. Five-year survival rate data for patients usi...and cardiac resynchronization therapy defibrillato...
Other Medicine Technology:Moffitt Cancer Center Signs Licensing Agreement with Frantz BioMarkers, LLC 2Boston Scientific Data Show Real-World Survival Rates for Implantable Cardiac Device Patients Exceed Rates From Clinical Trials 2Boston Scientific Data Show Real-World Survival Rates for Implantable Cardiac Device Patients Exceed Rates From Clinical Trials 3Boston Scientific Data Show Real-World Survival Rates for Implantable Cardiac Device Patients Exceed Rates From Clinical Trials 4
(Date:12/1/2009)... , , BELLEVUE, Wash., Dec 1 /PRNewswir...10 and Healthcare Channel Modernization solutions ...ranslator that facilitates HIPAA 4010A1 to HIPAA 5...-the-box 4010A1-5010 conversion maps, allows gener... between 4010A1 and 5010 in production, thus addre...
(Date:12/1/2009)... Highest rates seen in Central and South America,...Day News) -- About 50 percent of intensive care un...rease their risk of dying in the hospital, a new s...ed on a single day (May 8, 2007) on 13,796 patient...s. They found that 51 percent of patients were cla...
(Date:12/1/2009)... CDC urges H1N1 vaccination because pandemic,s co...Dec. 1 (HealthDay News) -- A U.S. health official ... to be on the wane nationally, but many experts ag...nter. , The flu is now widespread in 32 states ... R. Frieden, director of the U.S. Centers for Dise...
(Date:12/1/2009)... , Practitioners of any m...transcription are breathing a sigh of relief this ...e iPhone. The application, released over the holi... transcribe voice recordings to do so quickly and ... (PRWEB) December 1, 2009 -- T...
(Date:12/1/2009)... , , SMITHFIELD, R.I., D...otective equipment, bad assumptions are hazardous ... 25 years of government regulation, a handful of p...ering both the effectiveness of occupational Hear...aring. ,, A new free, white paper from Howard ...
Breaking Medicine News(10 mins):Health News:Edifecs Delivers Enhanced HIPAA 4010A1 to 5010 Migration Capabilities for Healthcare Organizations 2Health News:Edifecs Delivers Enhanced HIPAA 4010A1 to 5010 Migration Capabilities for Healthcare Organizations 3Health News:Half of ICU Patients Suffer From Infections 2Health News:Swine Flu Waning, But Could Return 2Health News:Swine Flu Waning, But Could Return 3Health News:Medical and Legal Professionals Find Relief Leveraging Apple iPhone App for Dictation and Transcription 'On the Go' 2Health News:New White Paper Details Six Common Bad Assumptions About Hearing Protection 2Health News:New White Paper Details Six Common Bad Assumptions About Hearing Protection 3
...helps identify cellular pathways involved in cance...y News) -- A protein called Lefty that regulates d...it the growth and spread of deadly melanomas and a...the Proceedings of the National Academy of Scienc...
...ICAGO --- A protein that governs development of hu... growth and spread of malignant melanoma, the dead...hers have discovered. Metastatic melanoma, which d...months. , The Northwestern scientists, led by r...
...Y, Wis., March 3 Shopko has some groundbreaking,n... bringing a fifth Shopko,store to Iowa as well as ...ill be the first Shopko store in Council Bluffs., ...ko stores. The new store in Council Bluffs will fe...
...NGELES (EMBARGOED UNTIL MARCH 3, 2008, AT 5 P.M. E...nstitute, Johns Hopkins University and China Medic...d for the first time the mechanisms by which varia...playing a role in heart function. , The study, co...
...it comes to a diagnosis of Alzheimer,s disease, wh...e truth as soon as possible appears to be the bett...ll-being of both patients and their caregivers, su...a 2004 review of research found about half of all ...
...N, Mass., March 3 Indevus,Pharmaceuticals, Inc. (...er,M.D. plans to retire as Indevus, Chief Executiv...ater this year on or prior to September 1, 2008., ...ny. Over the years, we have successfully developed...
Other Medicine News:Health News:Embryonic Stem Cell Protein Inhibits Melanoma 2Health News:Protein in embryonic stem cells control malignant tumor cells 2Health News:Protein in embryonic stem cells control malignant tumor cells 3Health News:Shopko Announces New Prototype Store in Council Bluffs 2Health News:Researchers describe mechanisms by which capon gene causes heart rhythm disturbances 2Health News:Dementia diagnosis brings relief, not depression 2Health News:Dementia diagnosis brings relief, not depression 3Health News:Indevus Pharmaceuticals Announces Retirement Plans For Its CEO and Chairman 2Health News:Indevus Pharmaceuticals Announces Retirement Plans For Its CEO and Chairman 3
Freedom® Twist Drainage Port Leg Bags
Hydrophilic Personal Catheter Closed System-Kit
Freedom® Flocked Back Fas-Tap&trade Drainage Port Leg Bags
Antibacterial Hydro Personal Catheter Closed System-Kit
Medicine Products: